Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0QB8Q
|
||||
Former ID |
DIB015071
|
||||
Drug Name |
EP-2167
|
||||
Synonyms |
EP-2167; MX-2167; Transferrin modulating apoptosis inducers (cancer); Transferrin modulating apoptosis inducers (cancer), EpiCept;Transferrin modulating apoptosis inducers (cancer), Maxim
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Preclinical | [547623] | ||
Company |
Maxim Pharmaceuticals Inc
|
||||
Target and Pathway | |||||
Target(s) | Transferrin | Target Info | Inducer | [547622] | |
KEGG Pathway | HIF-1 signaling pathway | ||||
Mineral absorption | |||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Pathway Interaction Database | EPHB forward signaling | ||||
HIF-1-alpha transcription factor network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.